STMN Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Straumann Holding (SWX: STMN)
›
Straumann Holding (SWX: STMN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 11,582 employees.
The shares were at 108.60 CHF on 19 November 2026, up 6.5% over 52 weeks. Its 52-week range is 73.02 CHF to 109.90 CHF: the price is 1.2% below the high and 48.7% above the low.
At a market capitalisation of 17.32B CHF, it trades at 47.0 times trailing earnings and 28.1 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, so STMN is valued in line with them. It pays a dividend yielding 0.93% (it pays out 43% of its earnings), against a median of 0.78% among the dividend payers in that peer group.
Straumann Holding reports return on equity of 16.5%, an operating margin of 24.7% and revenue up 2.3% year over year.
Its debt exceeds its cash by 60.02M CHF, a debt-to-equity ratio of 0.19. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 19 analysts cover the stock, with an average rating of Buy; their mean price target of 115.11 CHF is 6.0% above the current price. The next earnings report is expected on 24 February 2027.